questionsmedicales.fr
Phénomènes microbiologiques
Phénomènes physiologiques viraux
Interférence virale
Interférence virale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Randomized Controlled Trials as Topic
Diagnostic
5
Interférence virale
Tests virologiques
Symptômes
Infections virales
Modèles animaux
Interférence virale
Symptômes
5
Interférence virale
Virus
Symptômes
Infections virales
Diagnostic
Infections virales
Prévention
5
Hygiène
Transmission virale
Campagnes de vaccination
Infections virales
Traitements préventifs
Virus
Traitements
5
Traitements
Gestion des symptômes
Antiviraux
Interférence virale
Complications
Suivi médical
Immunomodulateurs
Réponse immunitaire
Complications
5
Complications
Respiratoires
Maladies chroniques
Asthme
Suivi médical
Complications
Prévisibilité
Patients à risque
Âge avancé
Immunodépression
Facteurs de risque
5
Facteurs de risque
Immunodépression
Environnement
Infections virales
Antécédents médicaux
Maladies respiratoires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Interférence virale : Questions médicales les plus fréquentes",
"headline": "Interférence virale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Interférence virale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-15",
"dateModified": "2025-04-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Interférence virale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phénomènes physiologiques viraux",
"url": "https://questionsmedicales.fr/mesh/D018406",
"about": {
"@type": "MedicalCondition",
"name": "Phénomènes physiologiques viraux",
"code": {
"@type": "MedicalCode",
"code": "D018406",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G06.920"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Interférence virale",
"alternateName": "Viral Interference",
"code": {
"@type": "MedicalCode",
"code": "D014762",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jocelyne Piret",
"url": "https://questionsmedicales.fr/author/Jocelyne%20Piret",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Guy Boivin",
"url": "https://questionsmedicales.fr/author/Guy%20Boivin",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Shou-Wei Ding",
"url": "https://questionsmedicales.fr/author/Shou-Wei%20Ding",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Plant Pathology, University of California, Riverside, Riverside, CA, USA. Electronic address: shou-wei.ding@ucr.edu."
}
},
{
"@type": "Person",
"name": "Ke Li",
"url": "https://questionsmedicales.fr/author/Ke%20Li",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Daniel M Weinberger",
"url": "https://questionsmedicales.fr/author/Daniel%20M%20Weinberger",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Topical diquafosol versus hyaluronic acid for the treatment of dry eye disease: a meta-analysis of randomized controlled trials.",
"datePublished": "2023-05-10",
"url": "https://questionsmedicales.fr/article/37162564",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00417-023-06083-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema.",
"datePublished": "2024-07-16",
"url": "https://questionsmedicales.fr/article/39014498",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13063-024-08334-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Design and Methodological Issues of Within-Person (Split-Body) Randomized Controlled Trials Evaluating a Topical Treatment: A Systematic Review.",
"datePublished": "2023-03-29",
"url": "https://questionsmedicales.fr/article/36990057",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000530149"
}
},
{
"@type": "ScholarlyArticle",
"name": "Laser and light therapy combined with topical minoxidil for alopecia areata: a systematic review and meta-analysis of randomized controlled trials.",
"datePublished": "2023-02-17",
"url": "https://questionsmedicales.fr/article/36800063",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10103-023-03734-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nd:YAG/Er:YAG dual laser vs. topical steroid to treat vulvar lichen sclerosus: study protocol of a randomized controlled trial.",
"datePublished": "2023-05-05",
"url": "https://questionsmedicales.fr/article/37145134",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00404-023-07055-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes microbiologiques",
"item": "https://questionsmedicales.fr/mesh/D008827"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes physiologiques viraux",
"item": "https://questionsmedicales.fr/mesh/D018406"
},
{
"@type": "ListItem",
"position": 4,
"name": "Interférence virale",
"item": "https://questionsmedicales.fr/mesh/D014762"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Interférence virale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Interférence virale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Interférence virale",
"description": "Comment diagnostiquer l'interférence virale ?\nQuels tests sont utilisés pour l'interférence virale ?\nL'interférence virale peut-elle être détectée cliniquement ?\nQuels marqueurs biologiques indiquent l'interférence ?\nPeut-on utiliser des modèles animaux pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014762?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Interférence virale",
"description": "Quels sont les symptômes de l'interférence virale ?\nL'interférence virale provoque-t-elle des symptômes spécifiques ?\nComment l'interférence affecte-t-elle les symptômes ?\nLes symptômes varient-ils selon le virus ?\nL'interférence virale peut-elle masquer des symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D014762?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Interférence virale",
"description": "Comment prévenir l'interférence virale ?\nLes mesures d'hygiène aident-elles à prévenir l'interférence ?\nLes campagnes de vaccination sont-elles efficaces ?\nFaut-il éviter les contacts avec des personnes malades ?\nLes traitements préventifs sont-ils disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D014762?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Interférence virale",
"description": "Quels traitements sont efficaces contre l'interférence virale ?\nLes antiviraux aident-ils en cas d'interférence ?\nPeut-on utiliser des vaccins pour prévenir l'interférence ?\nComment gérer les complications liées à l'interférence ?\nLes traitements immunomodulateurs sont-ils efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D014762?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Interférence virale",
"description": "Quelles complications peuvent survenir avec l'interférence virale ?\nL'interférence virale peut-elle aggraver des maladies existantes ?\nComment surveiller les complications potentielles ?\nLes complications sont-elles prévisibles ?\nQuels facteurs augmentent le risque de complications ?",
"url": "https://questionsmedicales.fr/mesh/D014762?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Interférence virale",
"description": "Quels sont les principaux facteurs de risque d'interférence virale ?\nL'environnement joue-t-il un rôle dans l'interférence ?\nLes antécédents médicaux influencent-ils le risque ?\nLe mode de vie affecte-t-il le risque d'interférence ?\nLes voyages augmentent-ils le risque d'interférence virale ?",
"url": "https://questionsmedicales.fr/mesh/D014762?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'interférence virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests virologiques et l'observation des interactions virales."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'interférence virale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests PCR et des cultures cellulaires sont souvent utilisés pour détecter l'interférence."
}
},
{
"@type": "Question",
"name": "L'interférence virale peut-elle être détectée cliniquement ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes atypiques peuvent indiquer une interférence virale lors d'infections."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques indiquent l'interférence ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux d'anticorps ou de cytokines peuvent signaler une interférence virale."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des modèles animaux pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des modèles animaux sont souvent utilisés pour étudier l'interférence virale."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'interférence virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure fièvre, fatigue, et manifestations respiratoires."
}
},
{
"@type": "Question",
"name": "L'interférence virale provoque-t-elle des symptômes spécifiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes sont souvent non spécifiques et varient selon les virus impliqués."
}
},
{
"@type": "Question",
"name": "Comment l'interférence affecte-t-elle les symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut atténuer ou aggraver les symptômes d'une infection virale coexistante."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le virus ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent des virus en interaction et de l'état immunitaire de l'hôte."
}
},
{
"@type": "Question",
"name": "L'interférence virale peut-elle masquer des symptômes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut masquer des symptômes d'autres infections virales, rendant le diagnostic difficile."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'interférence virale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination et l'hygiène personnelle sont essentielles pour réduire le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les mesures d'hygiène aident-elles à prévenir l'interférence ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mesures d'hygiène rigoureuses peuvent réduire la transmission des virus."
}
},
{
"@type": "Question",
"name": "Les campagnes de vaccination sont-elles efficaces ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles réduisent l'incidence des infections virales et donc le risque d'interférence."
}
},
{
"@type": "Question",
"name": "Faut-il éviter les contacts avec des personnes malades ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les contacts avec des personnes infectées peut réduire le risque d'interférence."
}
},
{
"@type": "Question",
"name": "Les traitements préventifs sont-ils disponibles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements préventifs existent, mais leur utilisation dépend des virus en circulation."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre l'interférence virale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique; la gestion des symptômes est essentielle."
}
},
{
"@type": "Question",
"name": "Les antiviraux aident-ils en cas d'interférence ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux peuvent être utiles, mais leur efficacité dépend des virus impliqués."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des vaccins pour prévenir l'interférence ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des vaccins peuvent réduire le risque d'infection, mais ne préviennent pas toujours l'interférence."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées à l'interférence ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite une approche symptomatique et un suivi médical."
}
},
{
"@type": "Question",
"name": "Les traitements immunomodulateurs sont-ils efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent aider à réguler la réponse immunitaire, mais leur efficacité varie selon les cas."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'interférence virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications respiratoires et neurologiques peuvent survenir en cas d'interférence."
}
},
{
"@type": "Question",
"name": "L'interférence virale peut-elle aggraver des maladies existantes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut exacerber des maladies chroniques comme l'asthme ou la BPCO."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications potentielles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier est crucial pour détecter et gérer les complications."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles, surtout chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les maladies sous-jacentes et l'immunodépression augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'interférence virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immunodépression, l'âge avancé et les infections coexistantes."
}
},
{
"@type": "Question",
"name": "L'environnement joue-t-il un rôle dans l'interférence ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des environnements surpeuplés ou insalubres augmentent le risque d'infections virales."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies respiratoires ou virales augmentent le risque d'interférence."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il le risque d'interférence ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'interférence virale ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages dans des zones à forte incidence virale peuvent accroître le risque d'infection."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 11/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Plant Pathology, University of California, Riverside, Riverside, CA, USA. Electronic address: shou-wei.ding@ucr.edu.
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Microbiology and Center for Women Infectious Disease Research, Washington University School of Medicine, St. MO.
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Microbiology and Center for Women Infectious Disease Research, Washington University School of Medicine, St. MO.
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, 06520.
Department of Immunobiology, Yale School of Medicine, New Haven, CT, 06520.
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, 06520.
Department of Immunobiology, Yale School of Medicine, New Haven, CT, 06520.
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, 06520.
Department of Immunobiology, Yale School of Medicine, New Haven, CT, 06520.
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, 06520.
Department of Immunobiology, Yale School of Medicine, New Haven, CT, 06520.
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Affiliations :
School of Life Sciences, University of Science and Technology of China, Hefei, China.
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Affiliations :
The key Laboratory for Green Organic Synthesis and Application of Hunan Province, College of Chemistry, Xiangtan University, Xiangtan 411105, China.
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Affiliations :
Department of Biomaterials, School of Ophthalmology & Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, PR China.
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Affiliations :
Department of Biomaterials, School of Ophthalmology & Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, PR China.
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Affiliations :
Department of Biomaterials, School of Ophthalmology & Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, PR China.
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Affiliations :
Department of Biomaterials, School of Ophthalmology & Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, PR China.
Publications dans "Interférence virale" :
2 publications dans cette catégorie
Affiliations :
Department of Biomaterials, School of Ophthalmology & Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, PR China.
Publications dans "Interférence virale" :
Diquafosol enhances fluid transfer and mucin secretion on ocular surface, which has been suggested as an effective treatment for dry eye disease (DED). The aim of the systematic review and meta-analys...
Relevant randomized controlled trials were obtained via search of electronic including PubMed, Embase, Cochrane Library, and Web of Science. A random-effects model was used to pool the results after i...
A total of nine RCTs involving 1295 patients with DED were included in the meta-analysis. Compared to treatment with 0.1% HA, topical treatment with 3% diquafosol significantly improved the Ocular Sur...
Topical treatment with 3% diquafosol may be more effective than 0.1% HA for patients with DED. However, the long-term efficacy and tolerability of diquafosol still need to be determined....
Narrowband ultraviolet B (NB-UVB) phototherapy is commonly prescribed for patients with moderate-to-severe atopic eczema (AE). The efficacy of NB-UVB, however, has not yet properly been established, a...
A pragmatic, multicenter, PROBE trial will be performed with 1:1 randomization of 316 adult patients with moderate-to-severe AE who have inadequate disease control with topical therapy and who are eli...
The UPDATE trial aims to provide high-quality evidence regarding the (cost-)effectiveness and safety of NB-UVB phototherapy in moderate-to-severe AE patients. Challenges that are addressed in the prot...
ClinicalTrials.gov NCT05704205. Registered on December 8, 2022....
Topical drugs are often used as first-line treatment for dermatological conditions. A within-person design may then be well adapted: it consists of randomizing lesions/body sites rather than patients,...
The aim of this review was to provide a methodological overview of within-person randomized trials (WP-RCTs) in dermatology....
We searched for eligible trials published between 2017 and 2021 in MEDLINE, Embase, and Central in dermatology journals and the 6 highest-impact-factor general medical journals. Two authors selected p...
From 1,034 articles identified, we included 54 WP-RCTs, mainly for acne vulgaris, psoriasis, actinic keratosis, and atopic dermatitis. In most of the trials, patients had only 2 lesions/body sites. In...
Our systematic review highlights that despite the publication of the CONSORT checklist extension for WP-RCTs in 2017, this design is rarely used, and when it is, there are methodological and reporting...
We aim to evaluate the clinical efficacy and safety of using laser and light combined with topical minoxidil for alopecia areata. We searched PubMed, Embase, Web of Science, the Cochrane Library, Chin...
Vulvar lichen sclerosus (LS) is a chronic debilitating inflammatory skin disease. Today, the gold standard is a life-long topical steroid treatment. Alternative options are highly desired. We present ...
We recruited 66 patients, 44 in the laser arm and 22 in the steroid arm. Patients with a physician-administered clinical LS score ≥ 4 were included. Participants received either four laser treatments ...
The findings of this trial have the potential to offer a novel treatment option for LS. The standardized Nd:YAG/Er:YAG laser settings and the treatment regime are presented in this paper....
NCT03926299....
Alopecia areata (AA) is a common autoimmune skin disease. Our study aimed to systematically evaluate the efficacy and safety of compound glycyrrhizin (CG) combined with topical minoxidil therapy in tr...
We searched the PubMed, EMBASE, Cochrane Library, Web of Science, CNKI, Wanfang, and VIP databases. Randomized controlled trials (RCTs) on CG combined with topical minoxidil therapy compared with topi...
11 RCTs and 1189 patients were included. Compared with topical minoxidil therapy alone, CG combined with topical minoxidil therapy was more effective at improving the clinical efficacy (RR = 1.36, 95%...
The current evidence indicates that CG combined with topical minoxidil therapy is effective and safe for AA. However, owing to the suboptimal quality of the included studies, more high-quality and lar...
The purpose was to identify and summarize the existing evidence on the efficacy and safety of the topical application of olive oil for preventing pressure ulcers (PUs). We included only randomized con...
To investigate the clinical efficacy and safety of topical difamilast in mild-to-moderate atopic dermatitis (AD)....
Only randomized controlled trials (RCTs) that compared topical difamilast with vehicle treatment for patients with AD were included. PubMed, Web of Science, Ovid Medline, Cochrane Library, ClinicalTri...
Five studies enrolling a total of 1009 patients with mild-to-moderate AD were identified. Compared with the topical vehicle, topical difamilast was associated with a significantly higher success rate ...
This meta-analysis suggests that topical difamilast is an effective and safe treatment for mild-to-moderate AD....
Melasma is a chronic relapsing skin condition. Laser therapy is a new advancement in treatment. Whether the topical application of tranexamic acid (TXA) increases the efficacy of laser therapy in mela...
Randomized controlled trials are used to estimate the causal effect of a treatment on a health outcome of interest in a patient population. Often the specified treatment in a randomized controlled tri...
We use causal reasoning to explain why randomized controlled trials of biomarker targets can arrive at conflicting or misleading conclusions. We describe four key threats to the validity of trials of ...
We illustrate these findings using evidence from 15 randomized controlled trials of blood pressure targets for management of hypertension. Randomized trials of blood pressure targets exhibit substanti...
Researchers should critically assess meta-analyses of trials of targets for variation in the types, distributions, and off-target effects of therapies studied. Trial investigators should release detai...